Falun Gong Protection Act
- Bill Number
- S. 817
- Origin Chamber
- Senate
- Congress
- 119th Congress, Session 1
- Policy Area
- International Affairs
- Status
- Introduced
- Latest Action
- 2025-03-03: Read twice and referred to the Committee on Foreign Relations.
- Last Updated
- 2026-03-30T22:42:00Z
AI-Generated Summary
Purpose of the Legislation
The Falun Gong Protection Act (S. 817) aims to address and deter forced organ harvesting in the People's Republic of China (PRC), particularly targeting state-sponsored activities linked to the persecution of Falun Gong practitioners and other prisoners of conscience. It establishes U.S. policy to oppose such practices through sanctions, international coordination, and reporting requirements, while avoiding cooperation with China in organ transplantation as long as the Chinese Communist Party (CCP) remains in power.
Key Provisions
- Statement of U.S. Policy:
- Prohibits U.S. cooperation with China in organ transplantation while the CCP controls the government.
- Requires measures, including sanctions, to pressure the CCP to end state-sponsored organ harvesting.
- Directs the U.S. to collaborate with allies, partners, and international organizations to expose China's persecution of Falun Gong.
- Mandates close coordination with the global community on targeted sanctions and visa restrictions.
- Imposition of Sanctions:
- The President must create and maintain a list of foreign persons (individuals or entities outside the U.S.) who knowingly engage in or facilitate involuntary organ harvesting in China.
- Initial list due within 180 days of enactment; updates as new information emerges, annually for the first year, and then yearly until the law sunsets.
- List submitted to congressional committees in unclassified form, with possible classified additions.
- Sanctions on listed persons include:
- Property Blocking: Freezes and prohibits transactions involving their assets in the U.S. or under U.S. control, using powers from the International Emergency Economic Powers Act (IEEPA, a law allowing the President to regulate international economic transactions during emergencies).
- Visa and Entry Restrictions: Bars listed aliens (non-U.S. citizens) from entering the U.S., revokes existing visas immediately, and denies immigration benefits under the Immigration and Nationality Act.
- Penalties: Violations of sanctions regulations carry fines and imprisonment as outlined in IEEPA.
- Exceptions and Waivers:
- No sanctions for U.S. intelligence/law enforcement activities, national security operations, or humanitarian aid (e.g., food, medicine, or related transport).
- Case-by-case waivers available if vital to U.S. national security; requires periodic reports to Congress on waiver use.
- Exemptions for U.N. headquarters agreements or other international obligations.
- Sanctions do not apply to importing goods (defined as articles, materials, or products, excluding technical data).
- Sunset Clause: Authority expires 5 years after enactment.
- Reporting Requirements:
- Within one year of enactment, the Secretary of State (in consultation with the Secretary of Health and Human Services and the Director of the National Institutes of Health) must submit a report to congressional committees on China's organ transplant policies.
- Covers: Official and actual policies on transplants (including for prisoners like Falun Gong practitioners); estimated annual transplants and voluntary donors; organ sources; transplant wait times and feasibility; U.S. grants supporting China-related transplant research over the past 10 years; and whether Falun Gong persecution qualifies as an "atrocity" under U.S. law (defined as widespread or systematic violence against civilians, like genocide or crimes against humanity).
- Report in unclassified form, with possible classified annex.
- Definitions:
- Key terms include "alien" (non-U.S. citizen), "foreign person" (non-U.S. individual or entity), "knowingly" (actual or should-have-known awareness), and "U.S. person" (U.S. citizens, permanent residents, U.S.-based entities, or anyone in the U.S.).
- "Appropriate congressional committees" are specified as House Foreign Affairs, Senate Foreign Relations, and Senate Banking committees.
Significant Changes to Existing Law
- Introduces a new, targeted sanctions regime under IEEPA specifically for forced organ harvesting in China, which was not previously addressed in U.S. law.
- Builds on existing frameworks like IEEPA for economic sanctions and the Immigration and Nationality Act for visa restrictions but creates mandatory listing and reporting obligations tied to human rights abuses.
- Adds a unique reporting mandate on China's transplant system and U.S. funding involvement, potentially influencing future appropriations or collaborations.
- Explicitly excludes sanctions on goods imports, distinguishing it from broader trade sanctions laws.
Potential Impacts
- On Government Agencies: Requires the President, State Department, Health and Human Services, and National Institutes of Health to compile lists, impose sanctions, and produce reports, increasing administrative workload and inter-agency coordination. Congressional oversight is enhanced through regular updates.
- On Citizens: U.S. persons (individuals or businesses) may face restrictions on dealings with sanctioned foreign entities, potentially disrupting international medical or financial transactions. It protects U.S. interests by avoiding entanglement in alleged unethical practices.
- On International Relations: Could strain U.S.-China ties by directly challenging CCP policies, escalating human rights tensions. Encourages multilateral efforts, potentially strengthening alliances on sanctions but risking Chinese retaliation in trade or diplomacy. No direct impact on U.S. citizens' travel or imports.
Main Stakeholders Affected
- Primary Targets: Foreign persons in China (e.g., officials, medical professionals, or entities) involved in forced organ harvesting, especially those linked to CCP or state-run facilities.
- Beneficiaries: Falun Gong practitioners, other prisoners of conscience, and human rights advocates who may gain international visibility and protection from persecution.
- U.S. Entities: Government agencies (as noted above), medical researchers, and institutions receiving or granting funds for China-related transplant work, which could face scrutiny or funding cuts.
- International Actors: Allies and multilateral bodies (e.g., U.N.) for coordination; Chinese government and global transplant community, potentially facing reputational damage or travel bans.
Notable Legal, Constitutional, or Political Implications
- Legal: Relies on executive authority under IEEPA, which has been upheld in courts for foreign policy but could face challenges if waivers or exceptions are seen as inconsistent. The "knowingly" standard requires evidence of awareness, balancing enforcement with due process.
- Constitutional: Aligns with Congress's power to regulate foreign commerce and immigration, and the President's role in foreign affairs; no direct First Amendment issues, but reporting on "atrocities" could inform future genocide prevention efforts under existing laws.
- Political: Signals strong U.S. bipartisan concern over China's human rights record (introduced by Senators Cruz, Johnson, Scott, and Tillis), potentially influencing broader U.S. policy on China. The 5-year sunset allows for reassessment, but it may politicize organ transplant research collaborations internationally.
This summary was generated by AI and may contain inaccuracies. Refer to the official source document for the authoritative text.
Sponsor
Cosponsors (8)
Sen. Johnson, Ron [R-WI], Sen. Scott, Rick [R-FL], Sen. Tillis, Thomas [R-NC], Sen. Rounds, Mike [R-SD], Sen. Young, Todd [R-IN], Sen. Cornyn, John [R-TX], Sen. McCormick, David [R-PA], Sen. Marshall, Roger [R-KS]
Recent Actions
- 2025-03-03: Read twice and referred to the Committee on Foreign Relations.
- 2025-03-03: Introduced in Senate
Bill Versions
- Falun Gong Protection Act — issued 2025-03-03 — PDF (11 pages)